Fig 1: RT-PCR assays for IL-6, JAK2, STAT3, and VEGF in the solid tumors. (A) IL-6, (B) JAK2, (C) STAT3 and (D) VEGF expression; Column charts demonstrate data as mean ± S.D., and comparison was achieved by applying one-way ANOVA and Bonferroni’s test at P less than 0.05. * Versus the EST control, $ Versus the EST + Nifuroxazide (5 mg/kg) group.
Fig 2: ELISA assays for IL-6, JAK2, STAT3, TNF-a, NF-kB, VEGF, and angiostatin in the solid tumors. (A) IL-6, (B) JAK2, (C) STAT3, (D) TNF-a, (E) NF-kB, (F) VEGF, and (G) angiostatin, Column charts demonstrate data as mean ± S.D at P less than 0.05. * Versus the EST control, $ Versus the EST + Nifuroxazide (5 mg/kg) group.
Supplier Page from MyBioSource.com for Mouse Tyrosine-protein kinase JAK2 (JAK2) ELISA Kit